ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 725098 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 725098; 2) Community: the network communities that were significantly associated with the response to NSC 725098; 3) Molecule: the relationships between components within communities and NSC 725098; 4) MDR: the compounds that were significantly associated with the NSC 725098.

NSC Compound Enrichment Correlation
NSC 693169 Null 0.0237269271456697 0.3060636
NSC 706992 Null 0.0237269271456697 0.13601154
NSC 709358 1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol 0.0237269271456697 0.12398553
NSC 718564 Null 0.0237269271456697 0.023617102
NSC 718630 Null 0.0237269271456697 0.25460332
NSC 718781 Erlotinib hydrochloride 0.0237269271456697 -0.17648622
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.0237269271456697 0.16575056
NSC 720497 Null 0.0237269271456697 -0.020996265
NSC 726217 Combretastatin A4-analogue 0.0237269271456697 0.53224949
NSC 728078 2-carboxy-(2'-furyl)-7-chloro-3-trifluoromethylquinoxaline 1,4-dioxide 0.0237269271456697 0.44579338
Total:159  Current:112    [First] [Prev] [Next] [Last]